This inventor holds 5 USPTO granted patents and 11 published patent applications and 1 EPO patent. Top assignee: Aciont, Inc.. Active years: 2012-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2019
Title: John W. Higuchi: Innovator in Ocular Drug Delivery
Introduction
John W. Higuchi is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of ocular drug delivery, holding a total of 5 patents. His work focuses on developing innovative devices and methods to enhance the delivery of active agents into the eye.
Latest Patents
One of Higuchi's latest inventions is the Intrascleral drug delivery device and associated methods. This invention provides methods and devices for delivering an active agent into the eye of a subject. The ocular drug delivery device includes a housing that couples to the eye and a corneal seal that encircles the cornea during use. The device is designed to fluidically isolate the corneal region from the scleral region, allowing for effective drug delivery.
Another significant patent is the Intraocular iontophoretic device and associated methods. This device includes an anode assembly and a cathode assembly that electrically couple to a power source. The device is configured to contact the surface of the eye, facilitating the delivery of active agents through iontophoresis.
Career Highlights
Higuchi's career is marked by his dedication to advancing ocular drug delivery technologies. His innovative approaches have the potential to improve treatment outcomes for patients requiring eye medications. His work at Aciont, Inc. has positioned him as a leader in this specialized field.
Collaborations
Higuchi collaborates with talented individuals such as S. Kevin Li and Matthew S. Hastings. These partnerships enhance the development of cutting-edge technologies in ocular drug delivery.
Conclusion
John W. Higuchi is a pioneering inventor whose work in ocular drug delivery has the potential to transform patient care. His innovative patents reflect his commitment to improving medical technology and enhancing the effectiveness of eye treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
